Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00378404 · ClinicalTrials.gov registry record · Phase 1
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
A Phase 1 study, sponsored by Susanne Arnold.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00378404 is a Phase 1 study that was terminated before completion, run by Susanne Arnold. The registered enrollment target is 10 participants.
The verdict
NCT00378404, a Phase 1 study, was terminated before completion, sponsored by Susanne Arnold.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the maximum tolerated dose of low-dose radiation in combination with Docetaxel in recurrent or metastatic non-small cell lung cancer for second-line therapy.
Interventions
- DRUG Docetaxel
- RADIATION Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2004-11 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00378404
The ClinicalTrials.gov registry entry for NCT00378404 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Susanne Arnold, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Docetaxel is the first listed.
NCT00378404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00378404 about?
NCT00378404 is a clinical study titled "Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC". The purpose of this study is to assess the maximum tolerated dose of low-dose radiation in combination with Docetaxel in recurrent or metastatic non-small cell lung cancer for second-line therapy.
What is the current status of trial NCT00378404?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2004-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00378404?
The interventions under investigation include: Docetaxel (DRUG), Radiation (RADIATION).
Who is sponsoring clinical trial NCT00378404?
This trial is sponsored by Susanne Arnold, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.